Relentless increase of resistance to fluoroquinolones and expanded-spectrum cephalosporins in Escherichia coli: 20years of surveillance in resource-limited settings from Latin America

Clinical Microbiology and Infection

Volumn 19, Issue 4, 2013, Pages 356-361

  Bartoloni, A ^a,b   Pallecchi, L ^c   Riccobono, E ^c   Mantella, A ^a   Magnelli, D ^a   Di Maggio, T ^c   Villagran, A L ^d   Lara, Y ^e   Saavedra, C ^f   Strohmeyer, M ^a   Bartalesi, F ^b   Trigoso, C ^g   Rossolini, G M ^c,h  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d Hospital Basico Villa Montes   (Bolivia)

^e Hospital San Antonio de los Sauces   (Bolivia)

^f Hospital Dermatologico   (Bolivia)

^g UNIVERSIDAD MAYOR DE SAN ANDRÉS   (Bolivia)

^h UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Bolivia; Commensals; CTX M; Enterobacteria; Healthy children

Indexed keywords

AMPICILLIN; BETA LACTAMASE CTX M; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID; PLASMID VECTOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; ESCHERICHIA COLI; GENE SEQUENCE; GENOTYPE; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; INFANT; NONHUMAN; NORMAL HUMAN; PLATING MEDIUM; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RECTUM; SCREENING; SOUTH AND CENTRAL AMERICA; URBAN AREA;

ENTEROBACTERIACEAE; ESCHERICHIA COLI;

EID: 84875544790     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2012.03807.x     Document Type: Article

References (18)

1. World Health Organization. Global strategy for containment of antimicrobial resistance. Geneva: WHO, 2001. Available from http://www.who.int/drugresistance/en. (last accessed 22 August 2011).
2. DiazGranados CA, Cardo DM, McGowan JE Jr. Antimicrobial resistance: international control strategies, with a focus on limited-resource settings. Int J Antimicrob Agents 2008; 32: 1-9.
3. Alekshun MN, Levy SB. Commensals upon us. Biochem Pharmacol 2006; 71: 893-900.
4. Bartoloni A, Benedetti M, Pallecchi L et al. Evaluation of a rapid screening method for detection of antimicrobial resistance in the commensal microbiota of the gut. Trans R Soc Trop Med Hyg 2006; 100: 119-125.
5. Bartoloni A, Pallecchi L, Benedetti M et al. Multidrug-resistant commensal Escherichia coli in children, Peru and Bolivia. Emerg Infect Dis 2006; 12: 907-913.
6. Bartoloni A, Pallecchi L, Fiorelli C et al. Increasing resistance in commensal Escherichia coli, Bolivia and Peru. Emerg Infect Dis 2008; 14: 338-340.
7. Bartoloni A, Cutts F, Leoni S et al. Patterns of antimicrobial use and antimicrobial resistance among healthy children in Bolivia. Trop Med Int Health 1998; 3: 116-123.
8. Pallecchi L, Malossi M, Mantella A et al. Detection of CTX-M-type beta-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru. Antimicrob Agents Chemother 2004; 48: 4556-4561.
9. Pallecchi L, Bartoloni A, Fiorelli C et al. Rapid dissemination and diversity of CTX-M extended-spectrum beta-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America. Antimicrob Agents Chemother 2007; 51: 2720-2725.
10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Supplement M100-S21. 2011: Wayne, PA, USA: CLSI.
11. Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum beta-lactamases. J Antimicrob Chemother 2006; 57: 154-155.
12. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests. Supplement M02-A10. 2009: Wayne, PA, USA: CLSI.
13. Riccobono E, Pallecchi L, Mantella A et al. Carriage of antibiotic-resistant Escherichia coli among healthy children and home-raised chickens: a household study in a resource-limited setting. Microb Drug Resist 2011; 18: 83-87.
14. Kim HB, Park CH, Kim CJ et al. Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother 2009; 53: 639-645.
15. Cavaco LM, Hasman H, Xia S et al. qnrD a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovis morbificans strains of human origin. Antimicrob Agents Chemother 2009; 53: 603-608.
16. Gordon DM, Clermont O, Tolley H et al. Assigning Escherichia coli strains to phylogenetic groups: multi-locus sequence typing versus the PCR triplex method. Environ Microbiol 2008; 10: 2484-2496.
17. Oteo J, Pérez-Vázquez M, Campos J. Extended-spectrum beta-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis 2010; 23: 320-326.
18. Radice M, Power P, Di Conza J et al. Early dissemination of CTX-M-derived enzymes in South America. Antimicrob Agents Chemother 2002; 46: 602-604.